Michelle V. Stacy Joins Flex Pharma’s Board of Directors

Go back to Michelle V. Stacy Joins Flex Pharma’s Board of Directors

Flex Pharma (FLKS) Tops Q4 EPS by 5c

March 8, 2016 7:04 AM EST

Flex Pharma (NASDAQ: FLKS) reported Q4 EPS of ($0.51), $0.05 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

... More